Baird Medical Investment Holdings BDMD
NASDAQ BDMD
$1.18 -0.01 (-1.22%)
At close: Aug 20, 2026 · 11:00 AM UTC

Baird Medical Investment Holdings (BDMD) Net Income towards Common Stockholders (2025)

Baird Medical Investment Holdings (BDMD) posted quarterly Net Income towards Common Stockholders of $65232.0 for Q2 2025.

Baird Medical Investment Holdings (BDMD) Net Income towards Common Stockholders (2025) Analysis & Trends

Baird Medical Investment Holdings (BDMD) has reported Net Income towards Common Stockholders for 1 consecutive years, with $65232.0 the latest figure, recorded in Q2 2025.

  • In Q2 2025, Net Income towards Common Stockholders changed N/A year-over-year to $65232.0; the TTM figure through Dec 2025 stood at $65232.0 (changed N/A YoY), while the FY2025 annual figure was -$27.3 million, down 319.04% from the prior year.
  • Net Income towards Common Stockholders was little changed at $65232.0 in Q2 2025 per BDMD's latest filing.
  • Across five years, Net Income towards Common Stockholders topped out at $65232.0 in Q2 2025 and bottomed at $65232.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Abbott Laboratories 200.08 Bn 194.48 Bn 7.27 Bn 928.00 Mn
2 Stryker 129.71 Bn 126.23 Bn 4.50 Bn 1.28 Bn
3 Medtronic 120.07 Bn 110.85 Bn 6.41 Bn 1.26 Bn
4 Boston Scientific 74.08 Bn 73.54 Bn 3.85 Bn 907.00 Mn
5 Edwards Lifesciences 52.68 Bn 48.43 Bn 1.35 Bn 241.40 Mn
6 Dexcom 34.51 Bn 32.56 Bn 830.00 Mn 249.10 Mn
7 GE HealthCare Technologies 34.03 Bn 31.92 Bn 2.18 Bn 574.00 Mn
8 Koninklijke Philips 26.51 Bn 23.19 Bn 4.55 Bn 621.86 Mn
9 Steris 23.20 Bn 22.72 Bn 684.20 Mn 201.00 Mn
10 Baird Medical Investment Holdings 32.67 Mn 32.28 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2025 65,232.00